Lancet Oncology

Immunotherapy for prostate cancer in sight

An international study carried out with involvement of the MedUni Vienna is giving hope to patients with advanced prostate cancer. In just a few years' time, Ipilumumab could be approved as a treatment for ...

May 26, 2014
popularity 5 / 5 (2) | comments 0

New drug shrinks brain tumours in melanoma patients

(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.

Oct 08, 2012
popularity not rated yet | comments 0 | with audio podcast

Concern at lack of teenage patients in cancer trials

Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments, according to a report from the National Cancer Research Institute (NCRI), ...

Jun 30, 2014
popularity not rated yet | comments 0

Cancer in EU cost EUR126 billion in 2009

The results, published in The Lancet Oncology, reveal substantial disparities between different countries in the EU in spending on health care and drugs for cancer, with Luxembourg and Germany spending the most on health ...

Oct 13, 2013
popularity not rated yet | comments 0